Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results

References

• 1 Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8–29.
  Medline Google Scholar
• 2 Siesling S, van Dijck JA, Visser O, Coebergh JW; Working Group of the Netherlands Cancer Registry. Trends in incidence of and mortality from cancer in the Netherlands in the period 1989–1998. Eur J Cancer 2003;39:2521–2530.
  Medline Google Scholar
• 3 Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J. The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 1994;179:29–32.
  Medline Google Scholar
• 4 Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995;273:577–585.
  Medline Google Scholar
• 5 Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer 1996;77:2318–2324.
  Medline Google Scholar
• 6 Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998;62:676–689.
  Medline Google Scholar
• 7 Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002;21(suppl 3):115–124.
  Google Scholar
• 8 Serova OM, Mazoyer S, Puget N, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am J Hum Genet 1997;60:486–495.
  Google Scholar
• 9 Szabo CI, King MC. Population genetics of BRCA 1 and BRCA2. Am J Hum Genet 1997;60:1013–1020.
  Medline Google Scholar
• 10 Krainer M, Silva Arrieta S, Fitzgerald MG, et al. Differential contribution of BRCA1 and BRCA2 to early-onset breast cancers. N Engl J Med 1997;336:1416–1421.
  Medline Google Scholar
• 11 Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 1997;349:1505–1510.
  Medline Google Scholar
• 12 Lakhani SR, Jacquemier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998;90:1138–1135.
  Medline Google Scholar
• 13 Porter DE, Dixon M, Smyth E, Steel CM. Breast cancer survival in BRCA1 carriers. Lancet 1993;341:184–185.
  Google Scholar
• 14 Verhoog LC, Brekelmans CT, Seynaeve C, et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998;351:316–321.
  Medline Google Scholar
• 15 Lehman CD, Schnall MD. Imaging in breast cancer: magnetic resonance imaging. Breast Cancer Res 2005;7:215–219.
  Medline Google Scholar
• 16 Heywang-Kobrunner SH, Heinig A, Pickuth D, et al. Interventional MRI of the breast: lesion localization and biopsy. Eur Radiol 2000;10:36–45.
  Medline Google Scholar
• 17 Liberman L, Morris EA, Dershaw DD, et al. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol 2003;181:1283–1293.
  Medline Google Scholar
• 18 Kuhl CK, Kreft BP, Bieling HB, et al. Dynamic breast MRI in premenopausal healthy volunteers: normal values of contrast enhancement and cycle phase dependency. Radiology 1997;203:137–144.
  Google Scholar
• 19 Müller-Schimpfle M, Ohmeauser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997;203:145–149.
  Google Scholar
• 20 Liberman L, Morris EA, Benton CL, Abramson AF, Dershaw DD. Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women. Cancer 2003;98:377–388.
  Medline Google Scholar
• 21 Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93:1095–1102.
  Medline Google Scholar
• 22 Morris EA, Liberman L, Ballo DJ. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181:619–626.
  Medline Google Scholar
• 23 Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000;63:53–60.
  Medline Google Scholar
• 24 Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215:267–279.
  Google Scholar
• 25 Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427–437.
  Medline Google Scholar
• 26 Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317–1325.
  Medline Google Scholar
• 27 Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769–1778.
  Medline Google Scholar
• 28 Sardanelli F, Podo F. Women with history of breast cancer excluded from screening programs: is it the right choice? [letter]. Radiology 2005;234:971.
  Google Scholar
• 29 Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet 1993;5:111–117.
  Medline Google Scholar
• 30 Rosenblum BB, Lee LG, Spurgeon SL, et al. New dye-labeled terminators for improved DNA sequencing patterns. Nucleic Acids Res 1997;25:4500–4504.
  Medline Google Scholar
• 31 Yager TD, Baron L, Batra R, et al. High performance DNA sequencing, and the detection of mutations and polymorphisms, on the Clipper sequencer. Electrophoresis 1999;20:1280–1300.
  Medline Google Scholar
• 32 Kourkine IV, Hestekin CN, Barron AE. Technical challenges in applying capillary electrophoresis-single strand conformation polymorphism for genetic analysis. Electrophoresis 2002;23:1375–1385.
  Medline Google Scholar
• 33 Jones AC, Austin J, Hansen N, et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 1999;45:1133–1140.
  Medline Google Scholar
• 34 American College of Radiology. Reporting system. In: Breast imaging reporting and data system (BI-RADS). 3rd ed. Reston, Va: American College of Radiology, 1998.
  Google Scholar
• 35 Mendelson EB, Berg WA, Merrit CR. Toward a standardized breast ultrasound lexicon: BI-RADS—ultrasound. Semin Roentgenol 2001;36:217–225.
  Medline Google Scholar
• 36 Sardanelli F, Iozzelli A, Fausto A. MR imaging of the breast: indications, established technique and new directions. Eur Radiol 2003;13(suppl 3):N28–N36.
  Medline Google Scholar
• 37 Sardanelli F, Fausto A, Iozzelli A, Rescinito G, Calabrese M. Dynamic breast magnetic resonance imaging: effect of changing the region of interest on early enhancement using 2D and 3D techniques. J Comput Assist Tomogr 2004;28:642–646.
  Medline Google Scholar
• 38 Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881–888.
  Google Scholar
• 39 Baum F, Fischer U, Vosshenrich R, Grabbe E. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 2002;12:1087–1092.
  Medline Google Scholar
• 40 Liberman L, Menell JH. Breast imaging reporting and data System (BI-RADS). Radiol Clin North Am 2002;40:409–430.
  Medline Google Scholar
• 41 Cancer statistics in developing countries: report on a WHO meeting, Nagoya, Japan, 18–22 August, 1981. World Health Stat Q 1983;36:213–217.
  Medline Google Scholar
• 42 Glantz SA. Primer of biostatistics. 4th ed. New York, NY: McGraw-Hill, 1997; 140–150.
  Google Scholar
• 43 Caines JS, Schaller GH, Iles SE, et al. Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991–2001. Can Assoc Radiol J 2005;56:82–93.
  Medline Google Scholar
• 44 Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001;19:924–930.
  Medline Google Scholar
• 45 Jassem J, Buchanan M, Janicke F, et al. The Hamburg statement: the partnership driving the European agenda on breast cancer. Eur J Cancer 2004;40:1810–1811.
  Medline Google Scholar
• 46 Robson M, Gilewki T, Haas B, et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998;16:1642–1649.
  Medline Google Scholar
• 47 Tilanus-Linthorst MM, Kriege M, Boetes C, et al. Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 2005;41:1610–1617.
  Medline Google Scholar
• 48 Chart PL, Franssen E. Management of women at increased risk for breast cancer: preliminary results from a new program. CMAJ 1997;157:1235–1242.
  Medline Google Scholar
• 49 Lalloo F, Boggis CR, Evans DG, Shenton A, Threlfall AG, Howell A. Screening by mammography, women with a family history of breast cancer. Eur J Cancer 1998;34:937–940.
  Medline Google Scholar
• 50 Morris EA. Breast MRI for cancer screening in high-risk patients. Appl Radiol 2005;May(suppl):4-9.
  Google Scholar